Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Apr 2023
In the second week of life, 83 percent of newborns who were fed formula milk had Clostridium difficile and Clostridium perfringens, but by the end of the third week, all infants had these infections.
Read Full NewsChildren and adolescents with venous thromboembolism, particularly children aged 4 years or younger, face a higher risk for mortality and economic burden.
Block reversal using sugammadex is associated with better respiratory outcomes than that using neostigmine in adults undergoing upper gastrointestinal endoscopic procedures, a study finds.
1.
Reversing the toxic relationship with high doses of chemotherapy in oncology.
2.
Risk of a Second Primary Melanoma Similar Regardless of Race/Ethnicity
3.
Ketamine plus psychotherapy for "excellent" PTSD
4.
Weight loss and cancer; no brain tumor blood test; no cervical cancer after HPV vaccination.
5.
Frontline Mosunetuzumab Shows High Response Rates in Follicular Lymphoma
1.
Revolutionizing Cancer Treatment: Harnessing the Power of AI in Histopathology
2.
Case Study: Artificial Intelligence in Early Cancer Detection
3.
Innovative Advances in Oncology for Specialists
4.
The Importance of Understanding Carboxyhemoglobin Levels in the Body: A Comprehensive Guide
5.
Clinical Perspectives in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
2.
Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
3.
Current Scenario of Cancer- The Incidence of Cancer in Men
4.
Efficient Management of First line ALK-rearranged NSCLC
5.
First-Line Maintenance Therapy for Metastatic Urothelial Carcinoma: Bridging Clinical Practice and Trials
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge